Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363,214,619
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
265,818,368
-
Shares change
-
-30,807,274
-
Total reported value, excl. options
-
$122,485,430
-
Value change
-
-$18,132,306
-
Put/Call ratio
-
24%
-
Number of buys
-
64
-
Number of sells
-
61
-
Price
-
$0.4608
Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q1 2025
As of 31 Mar 2025 LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) had 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 265,818,368 shares of stock of the company.
Largest 10 holders included Artal Group S.A., Siren, L.L.C., FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CIBC Private Wealth Group LLC, and UBS Group AG.
This table shows 124 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.